Atipamezole , sold under the brand name Antisedan among others, is a synthetic α2 adrenergic receptor antagonist used for the reversal of the sedative...
24 KB (2,110 words) - 00:27, 13 September 2024
during surgical procedures. α2-Adrenergic receptor antagonists such as atipamezole and yohimbine may be used to reverse the effects of xylazine in animals...
42 KB (4,341 words) - 19:30, 2 October 2024
2-MDP 3,3-Diphenylcyclobutanamine Amfonelic acid Amineptine Amiphenazole Atipamezole Atomoxetine Bemegride Benzydamine BTQ BTS 74,398 Centanafadine Ciclazindol...
181 KB (19,613 words) - 04:19, 10 October 2024
sometimes used in veterinary medicine (although now largely replaced by atipamezole) for reversing the effects of α2s such as medetomidine that are used...
3 KB (339 words) - 18:58, 20 August 2024
Xylazine Xylometazoline Antagonists 1-PP Adimolol Amesergide Aptazapine Atipamezole Atypical antipsychotics (e.g., asenapine, brexpiprazole, clozapine, lurasidone...
98 KB (9,190 words) - 01:56, 17 October 2024
2-MDP 3,3-Diphenylcyclobutanamine Amfonelic acid Amineptine Amiphenazole Atipamezole Atomoxetine Bemegride Benzydamine BTQ BTS 74,398 Centanafadine Ciclazindol...
165 KB (15,851 words) - 21:46, 14 October 2024
2-MDP 3,3-Diphenylcyclobutanamine Amfonelic acid Amineptine Amiphenazole Atipamezole Atomoxetine Bemegride Benzydamine BTQ BTS 74,398 Centanafadine Ciclazindol...
156 KB (15,356 words) - 07:01, 10 October 2024
effect as an alpha 2- adrenergic agonist. Effects can be reversed using atipamezole. It was developed by Orion Pharma. It is approved for dogs in the United...
15 KB (1,396 words) - 13:14, 12 September 2024
Xylazine Xylometazoline Antagonists 1-PP Adimolol Amesergide Aptazapine Atipamezole Atypical antipsychotics (e.g., asenapine, brexpiprazole, clozapine, lurasidone...
56 KB (5,142 words) - 03:23, 9 October 2024
Xylazine Xylometazoline Antagonists 1-PP Adimolol Amesergide Aptazapine Atipamezole Atypical antipsychotics (e.g., asenapine, brexpiprazole, clozapine, lurasidone...
88 KB (7,954 words) - 18:03, 10 October 2024